177 related articles for article (PubMed ID: 12421238)
1. Preliminary evaluation of soluble IL-2 receptor and type III procollagen N-terminal aminopeptide in pleural fluid for differentiating tuberculous, carcinomatous and parapneumonic pleural effusions.
Harita S; Nogami N; Kikuchi T; Kibata M
Respirology; 2002 Dec; 7(4):311-5. PubMed ID: 12421238
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of soluble interleukin 2 receptor in differentiating tuberculous and carcinomatous pleural effusions.
Chang SC; Hsu YT; Chen YC; Lin CY
Arch Intern Med; 1994 May; 154(10):1097-101. PubMed ID: 8185423
[TBL] [Abstract][Full Text] [Related]
3. [Type III procollagen N-terminal aminopeptide and type IV collagen 7S in pleural effusion fluid].
Tsuchiya Y; Nishikawa M; Iwamoto K; Kirioka T; Noguchi M; Watanabe A; Nishiwaki K; Nozaki Y; Nakane Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jun; 35(6):622-6. PubMed ID: 9294295
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of tuberculous pleuritis by the measurement of soluble interleukin 2 receptor in pleural fluid.
Porcel JM; Gázquez I; Vives M; Pérez B; Rubio M; Rivas MC
Int J Tuberc Lung Dis; 2000 Oct; 4(10):975-9. PubMed ID: 11055766
[TBL] [Abstract][Full Text] [Related]
5. Pleural fluid and serum soluble interleukin-2 receptors in pleural effusions.
Sarandakou A; Poulakis N; Rizos D; Phocas I
Anticancer Res; 1991; 11(3):1365-8. PubMed ID: 1888173
[TBL] [Abstract][Full Text] [Related]
6. Pleural SC5b-9 in differential diagnosis of tuberculous, malignant, and other effusions.
Hara N; Abe M; Inuzuka S; Kawarada Y; Shigematsu N
Chest; 1992 Oct; 102(4):1060-4. PubMed ID: 1395743
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of soluble interleukin 2 receptor alpha in the pleural fluid].
Ni SS; Gao ZL
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(2):81-2, 123. PubMed ID: 8221956
[TBL] [Abstract][Full Text] [Related]
8. [Elevated soluble interleukin-2 receptor and interleukin-2 receptor positive cells in carcinomatous pleural effusions].
Kojiro N; Moriwaki Y; Ito M; Nishiki M; Shirasaka T; Kokubu T
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jan; 28(1):100-4. PubMed ID: 2355670
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study of soluble interleukin 2 receptor and adenosine deaminase levels in tuberculous and other etiologies pleural fluids].
Avilés Inglés MJ; Contessotto C; Ontañón J; Muro M; Berlinches P; de la Torre J; Sánchez Gascón F; Alvarez López MR
Arch Bronconeumol; 1996 Dec; 32(10):523-6. PubMed ID: 9019312
[TBL] [Abstract][Full Text] [Related]
10. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI
Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
[TBL] [Abstract][Full Text] [Related]
11. Serum and pleural fluid N-Terminal-Pro-B-Type natriuretic peptide concentrations in the differential diagnosis of pleural effusions.
Yorgancıoğlu A; Ozgen Alpaydın A; Yaman N; Taneli F; Bayturan O; Sakar Coşkun A; Celik P
Tuberk Toraks; 2011; 59(1):1-7. PubMed ID: 21554224
[TBL] [Abstract][Full Text] [Related]
12. Triggering receptor expressed on myeloid cells-1 in pleural effusions: a marker of inflammatory disease.
Liu CL; Hsieh WY; Wu CL; Kuo HT; Lu YT
Respir Med; 2007 May; 101(5):903-9. PubMed ID: 17097866
[TBL] [Abstract][Full Text] [Related]
13. Neopterin, soluble interleukin-2 receptor and adenosine deaminase levels in pleural effusions.
Chiang CS; Chiang CD; Lin JW; Huang PL; Chu JJ
Respiration; 1994; 61(3):150-4. PubMed ID: 8047718
[TBL] [Abstract][Full Text] [Related]
14. Are soluble IL-2 receptor and IL-12p40 levels useful markers for diagnosis of tuberculous pleurisy?
Tural Önür S; Sökücü SN; Dalar L; Seyhan EC; Akbaş A; Altin S
Infect Dis (Lond); 2015 Mar; 47(3):150-5. PubMed ID: 25549699
[TBL] [Abstract][Full Text] [Related]
15. [Contribution of pleural fluid analysis to the diagnosis of pleural effusion].
Ferreiro L; Toubes ME; Valdés L
Med Clin (Barc); 2015 Aug; 145(4):171-7. PubMed ID: 25433793
[TBL] [Abstract][Full Text] [Related]
16. The etiology of pleural effusions in an area with high incidence of tuberculosis.
Valdés L; Alvarez D; Valle JM; Pose A; San José E
Chest; 1996 Jan; 109(1):158-62. PubMed ID: 8549179
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion.
Lee SH; Lee EJ; Min KH; Hur GY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Lee SY
Clin Biochem; 2013 Oct; 46(15):1484-8. PubMed ID: 23570862
[TBL] [Abstract][Full Text] [Related]
18. Superoxide dismutase 2 as a marker to differentiate tuberculous pleural effusions from malignant pleural effusions.
Wang M; Zhang Z; Wang X
Clinics (Sao Paulo); 2014; 69(12):799-803. PubMed ID: 25627990
[TBL] [Abstract][Full Text] [Related]
19. IL-8 in pleural effusion.
Ceyhan BB; Ozgün S; Celikel T; Yalçin M; Koç M
Respir Med; 1996 Apr; 90(4):215-21. PubMed ID: 8736655
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of the COMPLES Score for Differentiating Between Tuberculous Effusions with Low Pleural pH or Glucose and Complicated Parapneumonic Effusions.
Corral-Gudino L; García-Zamalloa A; Prada-González C; Bielsa S; Alexis D; Taboada-Gómez J; Dos-Santos-Gallego PR; Alonso-Fernández MA; Porcel JM
Lung; 2016 Oct; 194(5):847-54. PubMed ID: 27401009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
